Skip to content

Acupuncture as a Complementary Therapy for in Vitro Fertilization Patients: a Randomized Controlled Trial

Acupuncture as a Complementary Therapy for Infertile Patients on Treatment With in Vitro Fertilization: a Randomized Controlled Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03142490
Enrollment
100
Registered
2017-05-05
Start date
2016-12-01
Completion date
2018-12-31
Last updated
2017-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture, Anxiety, Infertility, Quality of Life, Stress

Keywords

Acupuncture, Infertility, In vitro fertilization, Quality of life, Stress, Anxiety

Brief summary

This is an open-label randomized controlled trial of the use of acupuncture in infertile patients receiving In Vitro Fertilization (IVF). Patients will be randomized into two groups: treatment group will receive acupuncture as a complementary approach to IVF and control group will receive the IVF treatment. Groups will be compared with the World Health Organization quality of life (WHOQOL-Bref), short-form 36 (SF-36), State Trait Anxiety Inventory (STAI) and Scope-Stress questionnaires.

Detailed description

This is an open-label randomized controlled trial of the use of acupuncture in infertile patients receiving In Vitro Fertilization (IVF). Patients will be randomized into two groups: treatment group will receive acupuncture as a complementary approach to IVF and control group will receive the IVF treatment. Groups will be compared with the World Health Organization quality of life (WHOQOL-Bref), short-form 36 (SF-36), State Trait Anxiety Inventory (STAI) and Scope-Stress questionnaires. In addition, data from medical records of infertile patients submitted to in vitro fertilization for treatment of infertility will be compared in the two different treatment groups (with and without acupuncture), such as the required dose of drugs for the treatment, number of ovarian follicles, number of oocytes captured, quality of oocytes, number of embryos, quality of embryos, pregnancy and abortion rates.

Interventions

OTHERAcupuncture

Acupuncture as a complementary therapy will be done in In vitro fertilization patients of the treatment group.

OTHERQuestionnaires

Patients in both groups will be evaluated by 4 different questionnaires (before and after 8 to 12 weeks)

Sponsors

Federal University of Minas Gerais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

In vitro fertilization patients will be randomized into two groups: treatment group (with complementary acupuncture) and control group (without complementary acupuncture).

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* female patient * age over 18 years * diagnosis of infertility with indication of IVF * agreement accept to participate in the study * signature of the consent form

Exclusion criteria

* history of previous contact with the acupuncture technique * severe neurological or psychiatric disorders that make it impossible to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Quality of lifeafter 8 acupuncture sessions (up to 12 weeks of follow-up)Quality of life evaluation by the WHOQOL-Bref questionnaire

Secondary

MeasureTime frameDescription
Quality of life 2after 8 acupuncture sessions (up to 12 weeks of follow-up)Quality of life evaluation by the SF-36 questionnaire
Stressafter 8 acupuncture sessions (up to 12 weeks of follow-up)Stress evaluation by the DASS 21 questionnaire
Pregnancy rateafter 8 acupuncture sessions (up to 12 weeks of follow-up)To compare the pregnancy rates from infertile patient records between both groups
Quality of life 3after 8 acupuncture sessions (up to 12 weeks of follow-up)Quality of life evaluation by the FERTIQOL questionnaire

Countries

Brazil

Contacts

Primary ContactRubens L Tavares, MD, PhD
rubens.ufmg@gmail.com+5531 3409 9485
Backup ContactVictor H Melo, MD, PhD
victormelo2401@gmail.com5531-3409-4592

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026